Atlas Trials

A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC

Clinical trial NCT03116984 · UNKNOWN

Trial details

NCT number
NCT03116984
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2017-01-01
Primary completion
2020-12-30
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.